Dashboard
Manage Tickers

CRNX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-maintains-buy-on-crinetics-pharmaceuticals-raises-price-target-to-69
HC Wainwright & Co. Maintains Buy on Crine...
08/09/2024 20:58:15

HC Wainwright & Co. analyst Douglas Tsao maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and raises the pri...

a-closer-look-at-11-analyst-recommendations-for-crinetics-pharmaceuticals
A Closer Look at 11 Analyst Recommendation...
08/09/2024 16:00:49

oppenheimer-reiterates-outperform-on-crinetics-pharmaceuticals-lowers-price-target-to-73
Oppenheimer Reiterates Outperform on Crine...
08/09/2024 15:20:00

Oppenheimer analyst Leland Gershell reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and lowers the pric...

crinetics-expects-cash--equivalents-to-be-sufficient-to-fund-its-current-operating-plan-into-2028
Crinetics Expects Cash & Equivalents To Be...
08/08/2024 21:15:16

crinetics-says-marc-wilson-will-be-transitioning-from-his-role-as-cfo-for-personal-reasons-initiates-search-for-successor
Crinetics Says Marc Wilson Will Be Transit...
08/08/2024 21:14:36

crinetics-pharmaceuticals-q2-2024-gaap-eps-094-misses-085-estimate-sales-399000k-miss-510000k-estimate
Crinetics Pharmaceuticals Q2 2024 GAAP EPS...
08/08/2024 20:39:05

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported quarterly losses of $(0.94) per share which missed the analyst consensus estim...

xpeng--quantumscape-are-among-top-11-mid-cap-stocks-that-performed-well-last-week-july-7-july-13-details
XPeng & QuantumScape Are Among Top 11 Mid ...
07/14/2024 17:22:37

10 mid-cap stocks jumped in last week, including QuantumScape, Lantheus Holdings, Sunrun, Kymera Therapeutics, Apogee Therapeut...

jp-morgan-maintains-overweight-on-crinetics-pharmaceuticals-raises-price-target-to-54
JP Morgan Maintains Overweight on Crinetic...
07/09/2024 14:59:04

JP Morgan analyst Jessica Fye maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Overweight and raises the price targe...

piper-sandler-maintains-overweight-on-crinetics-pharmaceuticals-maintains-97-price-target
Piper Sandler Maintains Overweight on Crin...
07/02/2024 17:29:11

Piper Sandler analyst Yasmeen Rahimi maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Overweight and maintains $97 p...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
07/01/2024 17:35:22

forecasting-the-future-11-analyst-projections-for-crinetics-pharmaceuticals
Forecasting The Future: 11 Analyst Project...
06/28/2024 17:01:20

hc-wainwright--co-reiterates-buy-on-crinetics-pharmaceuticals-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Crin...
06/28/2024 10:48:07

HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and maintains $60...

nvidia-to-rally-around-11-here-are-10-top-analyst-forecasts-for-tuesday
Nvidia To Rally Around 11%? Here Are 10 To...
06/04/2024 12:20:36

jmp-securities-reiterates-market-outperform-on-crinetics-pharmaceuticals-maintains-80-price-target
JMP Securities Reiterates Market Outperfor...
06/04/2024 12:19:30

JMP Securities analyst Jonathan Wolleben reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Market Outperform and mai...

oppenheimer-maintains-outperform-on-crinetics-pharmaceuticals-raises-price-target-to-74
Oppenheimer Maintains Outperform on Crinet...
06/04/2024 12:08:22

Oppenheimer analyst Leland Gershell maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and raises the price...

17-analysts-have-this-to-say-about-crinetics-pharmaceuticals
17 Analysts Have This To Say About Crineti...
06/04/2024 12:01:33

hc-wainwright--co-reiterates-buy-on-crinetics-pharmaceuticals-maintains-60-price-target
HC Wainwright & Co. Reiterates Buy on Crin...
06/04/2024 11:26:54

HC Wainwright & Co. analyst Douglas Tsao reiterates Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Buy and maintains $60...

crinetics-to-present-new-data-results-of-the-phase-3-pathfndr-2-trial-showing-increasing-evidence-positioning-once-daily-oral-paltusotine-as-potential-first-choice-treatment-option-for-acromegaly-at-endo-2024
Crinetics To Present New Data Results Of T...
06/03/2024 16:02:02

First Scientific Presentation of PATHFNDR-2 Acromegaly Safety and Efficacy Data Following Positive Topline Announcement, Showin...

baird-maintains-outperform-on-crinetics-pharmaceuticals-raises-price-target-to-62
Baird Maintains Outperform on Crinetics Ph...
05/23/2024 16:37:36

Baird analyst Brian Skorney maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Outperform and raises the price target ...

morgan-stanley-maintains-overweight-on-crinetics-pharmaceuticals-raises-price-target-to-70
Morgan Stanley Maintains Overweight on Cri...
05/23/2024 15:23:26

Morgan Stanley analyst Jeffrey Hung maintains Crinetics Pharmaceuticals (NASDAQ:CRNX) with a Overweight and raises the price...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION